Percheron Therapeutics (ASX: PER)

Last close As at 03/12/2025

AUD0.01

0.00 (14.29%)

Market capitalisation

AUD9m

Percheron Therapeutics is an international biotechnology company focused on the development of novel therapies for oncology and rare diseases.

Latest Insights

View More

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Dr James Garner

    Managing Director & CEO

  • Ms Deborah Ambrosini

    CFO and Company Secretary